Denmark grew to become the primary nation in Europe to completely abandon the AstraZeneca COVID-19 vaccine, coming after the nation and greater than a dozen different European Union nations suspended its utilization.
Denmark’s well being company director, Soren Brostrom, mentioned Denmark is not going to use the shot as a part of its vaccination marketing campaign—regardless of the World Health Organization (WHO) and EU’s European Medicines Agency (EMA) saying that the advantages of utilizing the AstraZeneca jab outweigh the negatives amid studies of uncommon blood clots.
“Overall, we must say that the results show that there is a real and serious side effect signal in the vaccine from AstraZeneca,” mentioned Brostrom in a press release. “Based on an overall consideration, we have therefore chosen to continue the vaccination programme for all target groups without this vaccine.”
Noting that it’s has been a “difficult decision” to make, Brostrom mentioned the “upcoming target groups for vaccination are less likely to become severely ill from COVID-19,” and officers “must weigh this against the fact that we now have a known risk of severe adverse effects from vaccination with AstraZeneca, even if the risk in absolute terms is slight.”
Danish officers beforehand mentioned that two individuals who had obtained the vaccine in opposition to the CCP (Chinese Communist Party) virus suffered from extreme blood clots. One of them died, they mentioned final month.
The CCP virus, often known as the novel coronavirus, is the virus that causes COVID-19.
In March, many of the international locations that stopped utilizing the AstraZeneca vaccine in the end resumed utilizing it.
On April 7, the EMA said that there’s a “possible link” between uncommon blood clots and the vaccine, including it “is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination.”
The assertion continued: “So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.”
The choice to not use AstraZeneca’s shot will push again the scheduled conclusion of Denmark’s vaccination scheme to early August from July 25, Danish officers mentioned. Denmark additionally makes use of the U.S.-made Pfizer/BioNTech vaccine, which requires two photographs.
Denmark was additionally the primary nation to cease utilizing the vaccine in March.
The Epoch Times has contacted AstraZeneca for remark.
AstraZeneca said in March that it “would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence,” including that “a careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country. ”
This week, U.S. well being businesses advisable that the single-shot Johnson & Johnson vaccine be suspended amid studies of blood clots. The transfer was decried by former President Donald Trump, who, in a press release, mentioned that he believes it was halted resulting from “possibly political reasons” because the Food and Drug Administration has extra “love for Pfizer.”
Reuters contributed to this report.
From The Epoch Times